Litchfield Caroline
SEC insider (Form 3/4/5 filer). CIK 0001854928. EVP & CFO at Merck & Co., Inc. (MRK) and 1 other issuer. 13 reported Form 4/5 transactions since Sep 2024; latest on May 5, 2026. Located in NEW YORK, NY.
Companies Litchfield Caroline has filed insider reports for
- Merck & Co., Inc. (MRK): Officer, EVP & CFO
- VERIZON COMMUNICATIONS INC (VZ): Director
Litchfield Caroline
CIK: 0001854928
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- May 5, 2026MRK
Merck & Co., Inc.
AwardDirectRestricted Stock Unit
15.9K shares- - May 5, 2026MRK
Merck & Co., Inc.
AwardDirectStock Option (Right to Buy)
46.6K shares- - Apr 29, 2026MRK
Merck & Co., Inc.
ExerciseDirect3.9K shares at avg. $110.03$433K - Apr 29, 2026MRK
Merck & Co., Inc.
Tax PaymentDirect1.9K shares at avg. $110.03$213K - Apr 1, 2026VZ
VERIZON COMMUNICATIONS INC
AwardIndirectPhantom Stock
5.1K shares- - Feb 4, 2026MRK
Merck & Co., Inc.
SaleDirect42K shares at avg. $119.61$5.0M - Feb 4, 2026MRK
Merck & Co., Inc.
ExerciseDirect42K shares at avg. $53.06$2.2M - Jan 26, 2026MRK
Merck & Co., Inc.
AwardDirect15.9K shares at avg. $107.40$1.7M - Apr 29, 2025MRK
Merck & Co., Inc.
AwardDirectRestricted Stock Unit
11.8K shares- - Apr 29, 2025MRK
Merck & Co., Inc.
AwardDirectStock Option (Right to Buy)
53.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 5, 2026 |  MRK Merck & Co., Inc. | Award Restricted Stock Unit | 15,908 | - | - | Direct |
| May 5, 2026 | MRK Merck & Co., Inc. | Award Stock Option (Right to Buy) | 46,566 | - | - | Direct |
| Apr 29, 2026 | MRK Merck & Co., Inc. | Exercise | 3,935 | $110.03 | $432,968 | Direct |
| Apr 29, 2026 | MRK Merck & Co., Inc. | Tax Payment | 1,938 | $110.03 | $213,238 | Direct |
| Apr 1, 2026 |  VZ VERIZON COMMUNICATIONS INC | Award Phantom Stock | 5,062 | - | - | Indirect |
| Feb 4, 2026 | MRK Merck & Co., Inc. | Sale | 41,997 | $119.61 | $5,023,312 | Direct |
| Feb 4, 2026 | MRK Merck & Co., Inc. | Exercise | 41,997 | $53.06 | $2,228,361 | Direct |
| Jan 26, 2026 | MRK Merck & Co., Inc. | Award | 15,852 | $107.40 | $1,702,505 | Direct |
| Apr 29, 2025 | MRK Merck & Co., Inc. | Award Restricted Stock Unit | 11,805 | - | - | Direct |
| Apr 29, 2025 | MRK Merck & Co., Inc. | Award Stock Option (Right to Buy) | 53,735 | - | - | Direct |
1-10 of 13 transactions